Literature DB >> 18719664

The FTO gene is associated with adulthood obesity in the Mexican population.

Marisela Villalobos-Comparán1, M Teresa Flores-Dorantes, M Teresa Villarreal-Molina, Maricela Rodríguez-Cruz, Ana C García-Ulloa, Lorena Robles, Adriana Huertas-Vázquez, Nubia Saucedo-Villarreal, Mardia López-Alarcón, Fausto Sánchez-Muñoz, Aarón Domínguez-López, Ruth Gutiérrez-Aguilar, Marta Menjivar, Ramón Coral-Vázquez, Gabriel Hernández-Stengele, Victor S Vital-Reyes, Victor Acuña-Alonzo, Sandra Romero-Hidalgo, Doris G Ruiz-Gómez, Daniela Riaño-Barros, Miguel F Herrera, Francisco J Gómez-Pérez, Philippe Froguel, Eduardo García-García, M Teresa Tusié-Luna, Carlos A Aguilar-Salinas, Samuel Canizales-Quinteros.   

Abstract

Common polymorphisms in the fat mass and obesity-associated gene (FTO) have shown strong association with obesity in several populations. In the present study, we explored the association of FTO gene polymorphisms with obesity and other biochemical parameters in the Mexican population. We also assessed FTO gene expression levels in adipose tissue of obese and nonobese individuals. The study comprised 788 unrelated Mexican-Mestizo individuals and 31 subcutaneous fat tissue biopsies from lean and obese women. FTO single-nucleotide polymorphisms (SNPs) rs9939609, rs1421085, and rs17817449 were associated with obesity, particularly with class III obesity, under both additive and dominant models (P = 0.0000004 and 0.000008, respectively). These associations remained significant after adjusting for admixture (P = 0.000003 and 0.00009, respectively). Moreover, risk alleles showed a nominal association with lower insulin levels and homeostasis model assessment of B-cell function (HOMA-B), and with higher homeostasis model assessment of insulin sensitivity (HOMA-S) only in nonobese individuals (P (dom) = 0.031, 0.023, and 0.049, respectively). FTO mRNA levels were significantly higher in subcutaneous fat tissue of class III obese individuals than in lean individuals (P = 0.043). Risk alleles were significantly associated with higher FTO expression in the class III obesity group (P = 0.047). In conclusion, FTO is a major risk factor for obesity (particularly class III) in the Mexican-Mestizo population, and is upregulated in subcutaneous fat tissue of obese individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719664     DOI: 10.1038/oby.2008.367

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  67 in total

1.  Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis.

Authors:  Haina Wang; Shuqian Dong; Hui Xu; Jun Qian; Jingyun Yang
Journal:  Mol Biol Rep       Date:  2011-12-22       Impact factor: 2.316

2.  No association of obesity gene FTO with body composition at the age of 6 months. The Generation R Study.

Authors:  D O Mook-Kanamori; L Ay; A Hofman; C M van Duijn; H A Moll; H Raat; A C S Hokken-Koelega; V W V Jaddoe
Journal:  J Endocrinol Invest       Date:  2010-05-28       Impact factor: 4.256

3.  Combined effects of FTO rs9939609 and MC4R rs17782313 on obesity and BMI in Chinese Han populations.

Authors:  Wei Huang; Yanlei Sun; Jiazhong Sun
Journal:  Endocrine       Date:  2010-11-10       Impact factor: 3.633

4.  Effects of RS9939609 gene variant in FTO gene on weight loss and cardiovascular risk factors after biliopancreatic diversion surgery.

Authors:  Daniel Antonio de Luis; Rocío Aller; Rosa Conde; Olatz Izaola; David Pacheco; Manuel Gonzalez Sagrado; David Primo
Journal:  J Gastrointest Surg       Date:  2012-02-04       Impact factor: 3.452

5.  Correlates of the FTO gene variant (rs9939609) and growth of American Indian infants.

Authors:  Nuananong Seal; Michael Weaver; Lyle G Best
Journal:  Genet Test Mol Biomarkers       Date:  2011-04-14

6.  Association of common genetic variants with diabetes and metabolic syndrome related traits in the Arizona Insulin Resistance registry: a focus on Mexican American families in the Southwest.

Authors:  Jacob DeMenna; Sobha Puppala; Geetha Chittoor; Jennifer Schneider; Joon Young Kim; Gabriel Q Shaibi; Lawrence J Mandarino; Ravindranath Duggirala; Dawn K Coletta
Journal:  Hum Hered       Date:  2014-07-08       Impact factor: 0.444

7.  The heterogeneity of the cigarette price effect on body mass index.

Authors:  George L Wehby; Charles J Courtemanche
Journal:  J Health Econ       Date:  2012-06-09       Impact factor: 3.883

8.  The common FTO variant rs9939609 is not associated with BMI in a longitudinal study on a cohort of Swedish men born 1920-1924.

Authors:  Josefin A Jacobsson; Ulf Risérus; Tomas Axelsson; Lars Lannfelt; Helgi B Schiöth; Robert Fredriksson
Journal:  BMC Med Genet       Date:  2009-12-09       Impact factor: 2.103

9.  Prevalence of loss-of-function FTO mutations in lean and obese individuals.

Authors:  David Meyre; Karine Proulx; Hiroko Kawagoe-Takaki; Vincent Vatin; Ruth Gutiérrez-Aguilar; Debbie Lyon; Marcella Ma; Helene Choquet; Fritz Horber; Wim Van Hul; Luc Van Gaal; Beverley Balkau; Sophie Visvikis-Siest; François Pattou; I Sadaf Farooqi; Vladimir Saudek; Stephen O'Rahilly; Philippe Froguel; Barbara Sedgwick; Giles S H Yeo
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

10.  Regulation and function of FTO mRNA expression in human skeletal muscle and subcutaneous adipose tissue.

Authors:  Louise G Grunnet; Emma Nilsson; Charlotte Ling; Torben Hansen; Oluf Pedersen; Leif Groop; Allan Vaag; Pernille Poulsen
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.